openPR Logo
Press release

Global Drug Delivery Devices Market In 2018–2025 With - Merck, BD,3M, Sanofi, Pfizer, Roche, Johnson & Johnson, Abbott Healthcare, Novartis, Bayer, Alkermes, Crossject, Baxter International, Inc.

11-16-2018 02:46 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Drug Delivery Devices

Drug Delivery Devices

The Global Drug Delivery Devices Market accounted to USD 1,027.0 billion and growing at a CAGR of 8.1% during the forecast period. The Global Drug Delivery Devices Market is highly fragmented and is based on new product launches and clinical results of products.


Get Sample Analysis of This Market Information: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-delivery-devices-market


Report Forecasting Regional and Global Analysis on Drug Delivery Devices Market By

· Route of Administration - Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal

· End-User - Hospitals, Clinics, Home Care Settings

· Distribution Channel - Direct Tenders, Hospital Pharmacies

· Geography

Drug delivery is the process of administering a pharmaceutical compound into the body for a therapeutic effect through various routes. Drug delivery improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by bypassing first-pass metabolism. Some of the major players operating in Drug Delivery Devices market are

· 3M Company

· Merck & Co., Inc.

· Pfizer Inc

· Johnson & Johnson

· Bayer AG

· F. Hoffmann-La Roche AG

· Sanofi

· Alkermes

· Abbott

· Novartis AG

· Valeant Pharmaceuticals International, Inc.

· Mylan Pharmaceuticals Inc.

· Antares Pharma

· Skye Pharma Plc.

· Nova Nordisk A/S

· Crossject

· Eli Lilly and Company

· Baxter International, Inc.

· Becton, Dickinson and Company

· Skyepharma AG amongst others

The report includes market shares of Global Drug Delivery Devices Market for global, Europe, North America, Asia Pacific and South America. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

Get TOC of Full Report: https://databridgemarketresearch.com/toc/?dbmr=global-drug-delivery-devices-market

· By product type, the global drug delivery devices market is segmented into

· Oral

· Pulmonary

· Injectable

· Ocular

· Nasal

· Topical

· Implantable

· Transmucosal

· Oral Drug Delivery is then segmented on the basis of form into

· Solid Oral Drugs

· Liquid Oral Drugs

· Semi-Solid Oral Drugs

· The form of solid oral drugs is further sub segmented into

· Tablets

· Capsules

· Powders

· Pills

· Liquid oral drug is sub segmented into

· Solutions

· Syrups

· Semi-solid oral drug is sub segmented into

· Gels

· Emulsions

· Elixirs

· Pulmonary Drug Delivery is segmented on the basis of

· Formulations

· Devices

· Nebulizers

· On the basis of device the pulmonary drug delivery segment is further sub-segmented into

· In Metered Dose Inhalers

· Dry Powder Inhaler

· Nebulizers are sub segmented into

· Jet Nebulizers

· Ultrasonic Nebulizers

· Soft Mist Nebulizers

· The injectable drug delivery segment is further segmented on the basis of product type and formulations.

· On the basis of type, the injectable drug delivery is segmented into self-injection devices, needle free injectors, auto-injectors, pen-injectors, wearable injectors.

· On the basis of formulations the market is segmented into conventional drug delivery formulations, novel drug delivery formulations and long acting injection formulations.

· The ophthalmic drug delivery is segmented on the basis of product type –

· Ocular Drug Delivery Devices

· Ocular Drug Delivery Formulations

· The ocular drug delivery is further segmented by product type,

· Drug Coated Contact Lenses

· Ocular Inserts

· The ocular drug delivery formulations is further segmented into liquid ocular drug delivery formulations and semi-solid ocular drug delivery formulations.

· On the basis of type the liquid ocular drug delivery formulations is further sub segmented into eye drops and sprays.

· On the basis of type the semi-solid ocular drug delivery formulations is sub segmented into gels and ointments.

· The nasal drug delivery is segmented by type in nasal drops, nasal sprays, nasal powders and nasal gels.

· The topical drug delivery is segmented on the basis of product type, transdermal drug delivery devices and topical drug delivery formulations. On the basis of product type the transdermal drug delivery devices is further sub segmented in transdermal patches and transdermal gels.

· On the basis of forms the topical drug delivery formulations are sub segmented into liquid topical drug delivery formulations, semi-solid topical drug delivery formulations, and solid topical drug delivery formulations.

· The liquid topical drug delivery formulations are further sub segmented into solutions and suspensions. The semi-solid topical drug delivery formulations are further sub segmented by type into creams, gels, ointments, pastes and lotions.

· On the basis of type the solid topical drug delivery formulations is further sub segmented into suppositories and powders.

· The implantable drug delivery is segmented by product type, activeimplantable drug delivery and passive implantable drug delivery.

· On the basis of product type the transmucosal drug delivery is segmented in oral transmucosal drug delivery and other transmucosal drug delivery.

· On the basis of type the oral transmucosal drug delivery is further sub segmented into buccal drug delivery and sublingual drug delivery.

· The other transmucosal drug delivery is further sub segmented into rectal transmucosal drug delivery and vaginal transmucosal drug delivery.

· On the basis of end users the market is segmented into

o Hospitals,

o Home healthcare,

o Clinics,

o Community healthcare and others.

· On the basis of distribution channel the market is segmented in

o Hospital pharmacies

o Pharmacy stores

o Direct tenders

· On the basis of geography, drug delivery devices market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa.

· Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., China, India, Japan, Australia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Major Market Drivers and Restraints:

· Growth in the number of diseases.

· Rise in Biologics Market

· Technological Advancement and New Product Launches are the factors which drives the market.

· Alternative drug delivery methods.

· Needlestick injuries & infections and Side Effects of Drugs.

· Regulatory requirements for the approval of devices restrain the market.

· Rising Demand for Biosimilars and Generic Drugs is the opportunity for the market.

· Pricing pressure is the challenge for the market.


Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-delivery-devices-market

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization and Getting Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Drug Delivery Devices Market In 2018–2025 With - Merck, BD,3M, Sanofi, Pfizer, Roche, Johnson & Johnson, Abbott Healthcare, Novartis, Bayer, Alkermes, Crossject, Baxter International, Inc. here

News-ID: 1377826 • Views:

More Releases from Data Bridge Market Research

Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 to 2030
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness. Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies and Competitive Landscape Top Players Analysis Industry Trends and Forecast
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug